Systems consequences of amplicon formation in human breast cancer
Name
Inaki-2014-Systems consequences.pdf
Size
1.45 MB
Format
Adobe PDF
Checksum (MD5)
f1aca18f80037871c65a79049b69b304
Author(s)
Inaki, Koichiro
Menghi, Francesca
Woo, Xing Yi
Wagner, Joel Patrick
Jacques, Pierre-Étienne
Lee, Yi Fang
Shreckengast, Phung Trang
Soon, Wendy WeiJia
Malhotra, Ankit
Teo, Audrey S.M.
Date Issued
September 2014
Journal
Genome Research
Publisher
Cold Spring Harbor Laboratory Press
Citation
Inaki, K., F. Menghi, X. Y. Woo, J. P. Wagner, P.-E. Jacques, Y. F. Lee, P. T. Shreckengast, et al. “Systems Consequences of Amplicon Formation in Human Breast Cancer.” Genome Research 24, no. 10 (September 3, 2014): 1559–1571.
Version
Final published version
Abstract
Chromosomal structural variations play an important role in determining the transcriptional landscape of human breast cancers. To assess the nature of these structural variations, we analyzed eight breast tumor samples with a focus on regions of gene amplification using mate-pair sequencing of long-insert genomic DNA with matched transcriptome profiling. We found that tandem duplications appear to be early events in tumor evolution, especially in the genesis of amplicons. In a detailed reconstruction of events on chromosome 17, we found large unpaired inversions and deletions connect a tandemly duplicated ERBB2 with neighboring 17q21.3 amplicons while simultaneously deleting the intervening BRCA1 tumor suppressor locus. This series of events appeared to be unusually common when examined in larger genomic data sets of breast cancers albeit using approaches with lesser resolution. Using siRNAs in breast cancer cell lines, we showed that the 17q21.3 amplicon harbored a significant number of weak oncogenes that appeared consistently coamplified in primary tumors. Down-regulation of BRCA1 expression augmented the cell proliferation in ERBB2-transfected human normal mammary epithelial cells. Coamplification of other functionally tested oncogenic elements in other breast tumors examined, such as RIPK2 and MYC on chromosome 8, also parallel these findings. Our analyses suggest that structural variations efficiently orchestrate the gain and loss of cancer gene cassettes that engage many oncogenic pathways simultaneously and that such oncogenic cassettes are favored during the evolution of a cancer.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1101/gr.164871.113
